phrykt

ASP Isotopes Inc. (ASPI): who owns it and who trades it

As of Nov 16, 2026, ASPI insiders reported 30 open-market sales worth $9.5M and 2 purchases worth $61.8K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Paul Elliot Mann (Director), with $6M. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling ASP Isotopes

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns ASPI

185 funds and institutions reported ASPI shares worth $411M at the end of Q2 2026, about 53% of the company. The largest holder is BlackRock, Inc. with 7.3%.

Funds and institutions (13F) 53%Everyone else 47%

10 largest owners, by share of the company

BlackRock, Inc.7.3%
Encompass Capital Advisors LLC5.2%
Vanguard Capital Management LLC4.0%
Rovida Investment Management Ltd3.3%
UBS Group AG2.6%
Geode Capital Management, LLC2.3%
Alyeska Investment Group, L.P.2.3%
State Street Corp2.1%
Exchange Traded Concepts, LLC1.8%
AWM Investment Company, Inc.1.3%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.9.22M7.32%$57.3M+11%
Encompass Capital Advisors LLC6.56M5.21%$40.8M-5%
Vanguard Capital Management LLC4.98M3.96%$31M-2%
Rovida Investment Management Ltd4.10M3.26%$25.5MNo change
UBS Group AG3.25M2.58%$20.2M+14%
Geode Capital Management, LLC2.95M2.34%$18.3M+7%
Alyeska Investment Group, L.P.2.84M2.26%$17.7M+6%
State Street Corp2.60M2.06%$16.1M+12%
Exchange Traded Concepts, LLC2.26M1.79%$14M+3%
AWM Investment Company, Inc.1.58M1.26%$9.8M-26%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.1.58M1.25%$9.8M+78%
Philadelphia Financial Management of San Francisco, LLC1.34M1.07%$8.4M+107%
Morgan Stanley1.16M0.92%$7.2M-26%
Vanguard Portfolio Management LLC1.12M0.89%$6.9M+14%
Northern Trust Corp1.01M0.80%$6.3M+7%
Charles Schwab Investment Management Inc935,3520.74%$5.8M+4%
Sixth Street Partners Management Company, L.P.935,3520.74%$5.8M–
Barclays PLC847,7810.67%$5.3M-16%
Marshall Wace, LLP835,6560.66%$5.2M–
Man Group plc828,3770.66%$5.2M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, ASPI insiders reported $61.8K of open-market purchases and $9.5M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$61.8K
2 trades, 1 people
Sales, 12 months
$9.5M
30 trades, 7 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Oct 16, 2026
Filed Oct 21, 2026

Purchases and sales by month

$3.5M$3.5MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Oct 16, 2026Heather KiesslingCFOSale21,830$2.19$47.8KForm 4
Oct 14, 2026Robert AinscowCOOSale plan22,500$2.11$47.6KForm 4
Sep 30, 2026Robert John Andrew RyanDirectorPurchase15,000$2.68$40.2KForm 4
Sep 28, 2026Robert John Andrew RyanDirectorPurchase8,000$2.70$21.6KForm 4
Sep 8, 2026Robert AinscowCOOSale8,438$4.29$36.2KForm 4
Sep 4, 2026Paul Elliot MannCEOSale83,759$4.10$343KForm 4
Sep 3, 2026Paul Elliot MannCEOSale83,758$3.92$328KForm 4
Sep 2, 2026Donald George AinscowVice presidentSale23,678$3.89$92.1KForm 4
Sep 2, 2026Robert AinscowCOOSale25,000$3.91$97.8KForm 4
Sep 2, 2026Paul Elliot MannCEOSale83,758$3.91$327KForm 4
Jul 1, 2026Heather KiesslingCFOSale23,124$6.28$145KForm 4
Jun 30, 2026Donald George AinscowVice presidentSale100,000$6.14$614KForm 4
Jun 30, 2026Todd WiderDirectorSale50,000$6.12$306KForm 4
Jun 30, 2026Michael GorleyDirectorSale30,000$6.27$188KForm 4
Jun 29, 2026Todd WiderDirectorSale50,000$6.25$312KForm 4
Jun 8, 2026Robert AinscowCOOSale8,438$7.00$59.1KForm 4
Jun 3, 2026Paul Elliot MannCEOSale83,759$7.76$650KForm 4
Jun 2, 2026Paul Elliot MannCEOSale83,758$8.29$694KForm 4
Jun 1, 2026Paul Elliot MannCEOSale83,758$7.88$660KForm 4
Apr 16, 2026Robert AinscowCOOSale22,500$5.21$117KForm 4
Apr 16, 2026Duncan MooreDirectorSale11,642$5.21$60.7KForm 4
Apr 15, 2026Heather KiesslingCFOSale23,124$5.48$127KForm 4
Mar 6, 2026Robert AinscowCOOSale25,000$4.51$113KForm 4
Mar 6, 2026Robert AinscowCOOSale8,438$5.44$45.9KForm 4
Mar 2, 2026Paul Elliot MannChairSale162,153$5.44$882KForm 4
Dec 18, 2025Heather KiesslingCFOSale80,000$5.80$464KForm 4
Dec 8, 2025Robert AinscowCEOSale8,438$6.20$52.3KForm 4
Dec 1, 2025Paul Elliot MannChairSale162,153$5.75$932KForm 4
Nov 25, 2025Robert AinscowCEOSale25,000$5.77$144KForm 4
Nov 25, 2025Paul Elliot MannDirectorSale50,000$5.77$288KForm 4
Nov 17, 2025Paul Elliot MannDirectorSale112,500$7.51$845KForm 4
Nov 17, 2025Robert AinscowCEOSale67,500$7.51$507KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Paul Elliot MannExecutive Officer, Director–$6MSep 4, 2026
Robert AinscowInterim CEO and COO–$1.2MOct 14, 2026
Heather KiesslingChief Financial Officer–$784KOct 16, 2026
Donald George AinscowEVP, Gen Counsel, Secretary–$706KSep 2, 2026
Todd WiderDirector–$618KJun 30, 2026
Michael GorleyDirector–$188KJun 30, 2026
Robert John Andrew RyanDirector$61.8K–Sep 30, 2026
Duncan MooreDirector–$60.7KApr 16, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

ASPI short interest

Very high short interest. 24.9% of ASPI shares are sold short: about 1 share in 4. Over the last 12 reports the number of shares short went up 36%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 31.37M ASPI shares were sold short, 24.9% of the shares outstanding, up 8.0% from the report before. At the average daily volume of 4.02M shares, buying them all back would take about 7.8 trading days (days to cover).

Shares short, % of all shares

24.9%May 15Oct 3026.0%

Days to cover

7.8May 15Oct 309.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202631.37M24.92%+8%4.02M7.8
Oct 15, 202629.05M23.07%+10%4.98M5.8
Sep 30, 202626.46M21.01%+1%4.98M5.3
Sep 15, 202626.07M20.71%+2%4.00M6.5
Aug 31, 202625.48M20.24%-5%3.18M8.0
Aug 14, 202626.78M21.27%+1%3.08M8.7
Jul 31, 202626.64M21.16%+10%4.36M6.1
Jul 15, 202624.24M19.25%+2%3.55M6.8
Jun 30, 202623.76M18.87%+3%4.95M4.8
Jun 15, 202623.09M18.34%+2%5.77M4.0
May 29, 202622.58M17.93%-2%6.98M3.2
May 15, 202623.08M18.33%-7%4.21M5.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

ASP Isotopes company events

ASP Isotopes filed 44 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 26, 2026.

  1. Oct 26, 2026AnnouncementShared information with investors. Filing
  2. Oct 15, 2026AnnouncementShared information with investors. Filing
  3. Oct 2, 2026AnnouncementShared information with investors. Filing
  4. Sep 8, 2026AnnouncementShared information with investors. Filing
  5. Aug 20, 2026AgreementRenergen Limited, a wholly-owned subsidiary of ASP Isotopes Inc., entered into a Second Amendment and Restatement Agreement with The Standard Bank of South Africa Limited. Filing
  6. Aug 20, 2026AnnouncementShared information with investors. Filing
  7. Aug 18, 2026AnnouncementShared information with investors. Filing
  8. Aug 6, 2026AnnouncementShared information with investors. Filing
  9. Aug 5, 2026AnnouncementShared information with investors. Filing
  10. Aug 4, 2026ResultsReleased financial results. Filing
  11. Jul 30, 2026AnnouncementShared information with investors. Filing
  12. Jul 28, 2026AnnouncementShared information with investors. Filing
  13. Jul 21, 2026AnnouncementShared information with investors. Filing
  14. Jul 16, 2026AnnouncementASP Isotopes Inc. is filing this Current Report on Form 8-K, including Exhibit 99.1, solely to retrospectively recast certain financial information and related disclosures included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the U.S.… Filing
  15. Jul 16, 2026AgreementASP Isotopes Inc. and Quantum Leap Energy LLC, a subsidiary of the Company, entered into separate, individually negotiated private exchange agreements with certain holders of QLE’s outstanding 8.0% Convertible Promissory Notes due November 19, 2030 to exchange approximately $109.2 million of the… Filing
  16. Jun 25, 2026AgreementASP Isotopes Inc., a Delaware corporation, entered into an Agreement and Plan of Merger, by and among ENDRA Life Sciences Inc., a Delaware corporation, Noble Africa LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of the Company, Renergen Limited, a company… Filing
  17. Jun 25, 2026AnnouncementShared information with investors. Filing
  18. Jun 23, 2026AnnouncementShared information with investors. Filing
  19. May 26, 2026AnnouncementShared information with investors. Filing
  20. May 20, 2026AnnouncementShared information with investors. Filing
  21. May 11, 2026AnnouncementShared information with investors. Filing
  22. May 6, 2026AnnouncementShared information with investors. Filing
  23. Apr 13, 2026AnnouncementShared information with investors. Filing
  24. Apr 10, 2026AnnouncementShared information with investors. Filing
  25. Mar 24, 2026AnnouncementShared information with investors. Filing
  26. Mar 23, 2026AnnouncementShared information with investors. Filing
  27. Mar 10, 2026AnnouncementShared information with investors. Filing
  28. Mar 6, 2026AnnouncementShared information with investors. Filing
  29. Mar 5, 2026AnnouncementShared information with investors. Filing
  30. Feb 23, 2026AnnouncementShared information with investors. Filing
  31. Feb 19, 2026AnnouncementShared information with investors. Filing
  32. Feb 17, 2026AnnouncementShared information with investors. Filing
  33. Jan 30, 2026AgreementASP Isotopes Inc., a Delaware corporation, entered into a Series Seed-1 Preferred Stock Purchase Agreement with Opeongo, Inc., a Delaware corporation, pursuant to which the Company agreed to purchase from Opeongo 4,356,918 shares of Opeongo’s Series Seed-1 Preferred Stock, $0.0001 par value per… Filing
  34. Jan 29, 2026AnnouncementShared information with investors. Filing
  35. Jan 12, 2026LeadershipASP Isotopes Inc. announced that in connection with the closing of the Company’s previously announced acquisition of Renergen Limited, on January 6, 2026, Stefano Marani, the Chief Executive Officer of Renergen, was appointed as the President, Electronics and Space, of the Company, and Nick… Filing
  36. Jan 7, 2026DealThis Current Report on Form 8-K is being filed in connection with the completion, on January 6, 2026, of the previously announced acquisition contemplated by the firm intention letter agreement, dated May 20, 2025, by and between ASP Isotopes Inc. and Renergen Limited, a public company incorporated… Filing
  37. Dec 19, 2025VoteReported shareholder vote results. Filing
  38. Dec 18, 2025AnnouncementShared information with investors. Filing
  39. Dec 17, 2025AnnouncementASP Isotopes Inc. issued a press release announcing that all required regulatory approvals and clearances have been obtained for the Company’s proposed offer to acquire all of the issued ordinary shares of Renergen Limited, pursuant to a scheme of arrangement under South African law pursuant to… Filing
  40. Dec 8, 2025LeadershipAs previously announced, effective January 19, 2026: (i), Paul Mann, the founder and Executive Chairman of ASP Isotopes Inc., will resume his role as the Company’s Chief Executive Officer and continue as Executive Chairman, and (ii) Robert Ainscow, who serves as Interim Chief Executive Officer… Filing
  41. Dec 3, 2025AnnouncementASP Isotopes Inc. issued a press release announcing Paul Mann the founder and Executive Chairman of the Company, will resume his role as the Company’s Chief Executive Officer and continue as Executive Chairman, effective January 19, 2026, after a temporary leave of absence. Filing
  42. Nov 28, 2025AgreementASP Isotopes Inc. and Renergen Limited, a South African company listed on the exchange operated by the JSE Limited and the Australian Securities Exchange, entered into a letter agreement to extend the date for the fulfillment of the conditions to the previously announced offer by the Company to… Filing
  43. Nov 21, 2025AnnouncementShared information with investors. Filing
  44. Nov 17, 2025AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

ASP Isotopes financials

Famous investors that hold ASPI

2 of the 50 well-known investors we track reported holding ASPI in their latest 13F filing. The largest position is Ken Griffin's, worth $6.6M.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20262.51M$6.6M0.0%+601%
Israel Englander · Millennium ManagementQ3 2026485,069$1.3M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named ASPI in the last 120 days.

FiledHolderFormStake
Nov 16, 2026AK Jensen Investment Management Ltd13G/A4.8%
Nov 16, 2026Encompass Capital Advisors LLC13G/A0.0%
Nov 16, 2026AK Jensen Investment Management Ltd13G/A4.8%
Nov 16, 2026Encompass Capital Advisors LLC13G/A0.0%

Questions about ASP Isotopes Inc. (ASPI) stock

Who owns the most ASPI stock?

The largest reported owner of ASP Isotopes Inc. (ASPI) is BlackRock, Inc., with 7.3% of the company. In total, 185 funds and institutions reported holding ASPI at the end of Q2 2026, together about 53% of the shares. See the largest owners.

Are ASPI insiders buying or selling?

In the last 12 months, ASPI insiders reported 2 open-market purchases worth $61.8K and 30 sales worth $9.5M. The latest trade was on Oct 16, 2026. See every trade.

What is the short interest in ASPI?

As of Oct 30, 2026, 31.37M ASPI shares were sold short, 24.9% of the shares outstanding, up 8.0% from the report before. At the average daily volume of 4.02M shares, buying them all back would take about 7.8 trading days (days to cover). See the history.

Which famous investors hold ASPI?

2 of the 50 well-known investors we track reported ASPI in their latest 13F filing, including Ken Griffin, Israel Englander. The largest position is worth $6.6M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.